| IL-33, but not thymic stromal lymphopoietin or IL-25, is central to mite and peanut allergic sensitization DK Chu, A Llop-Guevara, TD Walker, K Flader, S Goncharova, ... Journal of Allergy and Clinical Immunology 131 (1), 187-200. e8, 2013 | 375 | 2013 |
| Potentiating cancer immunotherapy using an oncolytic virus BW Bridle, KB Stephenson, JE Boudreau, S Koshy, N Kazdhan, ... Molecular Therapy 18 (8), 1430-1439, 2010 | 218 | 2010 |
| Natural killer cell education and the response to infection and cancer therapy: stay tuned JE Boudreau, KC Hsu Trends in immunology 39 (3), 222-239, 2018 | 192 | 2018 |
| Engineering dendritic cells to enhance cancer immunotherapy JE Boudreau, A Bonehill, K Thielemans, Y Wan Molecular therapy 19 (5), 841-853, 2011 | 155 | 2011 |
| NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis S Nersesian, SL Schwartz, SR Grantham, LK MacLean, SN Lee, ... Translational oncology 14 (1), 100930, 2021 | 136 | 2021 |
| Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus BW Bridle, JE Boudreau, BD Lichty, J Brunellière, K Stephenson, S Koshy, ... Molecular therapy 17 (10), 1814-1821, 2009 | 136 | 2009 |
| KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV JE Boudreau, TJ Mulrooney, JB Le Luduec, E Barker, KC Hsu The Journal of Immunology 196 (8), 3398-3410, 2016 | 134 | 2016 |
| KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation JE Boudreau, F Giglio, TA Gooley, PA Stevenson, JB Le Luduec, ... Journal of Clinical Oncology 35 (20), 2268-2278, 2017 | 131 | 2017 |
| Natural killer cell education in human health and disease JE Boudreau, KC Hsu Current opinion in immunology 50, 102-111, 2018 | 130 | 2018 |
| Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy PT Sobol, JE Boudreau, K Stephenson, Y Wan, BD Lichty, KL Mossman Molecular Therapy 19 (2), 335-344, 2011 | 118 | 2011 |
| Recombinant vesicular stomatitis virus transduction of dendritic cells enhances their ability to prime innate and adaptive antitumor immunity JE Boudreau, BW Bridle, KB Stephenson, KM Jenkins, J Brunellière, ... Molecular Therapy 17 (8), 1465-1472, 2009 | 98 | 2009 |
| KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma CJ Forlenza, JE Boudreau, J Zheng, JB Le Luduec, E Chamberlain, ... Journal of Clinical Oncology 34 (21), 2443-2451, 2016 | 84 | 2016 |
| Cell-extrinsic MHC class I molecule engagement augments human NK cell education programmed by cell-intrinsic MHC class I JE Boudreau, XR Liu, Z Zhao, A Zhang, LD Shultz, DL Greiner, B Dupont, ... Immunity 45 (2), 280-291, 2016 | 83 | 2016 |
| Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFNγ-producing NK cells K Karimi, JE Boudreau, K Fraser, H Liu, J Delanghe, J Gauldie, Z Xing, ... Molecular Therapy 16 (2), 411-418, 2008 | 75 | 2008 |
| Naturally killing the silent killer: NK cell-based immunotherapy for ovarian cancer S Nersesian, H Glazebrook, J Toulany, SR Grantham, JE Boudreau Frontiers in immunology 10, 1782, 2019 | 72 | 2019 |
| Genetic mutations and epigenetic modifications: driving cancer and informing precision medicine KM Coyle, JE Boudreau, P Marcato BioMed research international 2017 (1), 9620870, 2017 | 65 | 2017 |
| IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells JE Boudreau, KB Stephenson, F Wang, AA Ashkar, KL Mossman, LL Lenz, ... Cancer research 71 (7), 2497-2506, 2011 | 65 | 2011 |
| CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen … JD Bassett, TC Yang, D Bernard, JB Millar, SL Swift, AJR McGray, ... Blood, The Journal of the American Society of Hematology 117 (4), 1146-1155, 2011 | 55 | 2011 |
| Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8+ T-cell recall responses L Zhang, BW Bridle, L Chen, J Pol, D Spaner, JE Boudreau, A Rosen, ... Blood, The Journal of the American Society of Hematology 121 (13), 2432-2439, 2013 | 51 | 2013 |
| Development of a novel multiplex PCR assay to detect functional subtypes of KIR3DL1 alleles JE Boudreau, JB Le Luduec, KC Hsu PloS one 9 (6), e99543, 2014 | 40 | 2014 |
Katharine HsuProfessor of Medicine, Memorial Sloan-Kettering Cancer CenterPotvrđena adresa e-pošte na mskcc.org
